I am a molecular biologist and postdoctoral researcher with expertise in protein biochemistry and translational research. My Ph.D. work focused on alpha-1-antitrypsin (AAT), a key plasma inhibitor of serine proteases, with a particular emphasis on the functional effects of amino acid variations in its Reactive Center Loop (RCL) and their impact on protease inhibition and secretion. During this period, I characterized 23 RCL variants—including naturally occurring mutations—and assessed their secretion efficiency and anti-elastase activity using cellular models, immunoblotting, and enzymatic assays. Additionally, I developed a polymeric AAT standard for ELISA-based quantification of Z-AAT polymers in plasma, contributing to the understanding of the molecular basis of disease severity in ZZ homozygous patients.
Currently, as a postdoctoral fellow, I investigate the role of post-translational modifications (PTMs), particularly N-glycosylation, in viral protein function and host-pathogen interactions. I combine advanced virological models, including pseudovirus systems, with proteomics and functional assays to study how specific modifications affect viral infectivity and immune recognition. My work aims to integrate molecular insights into translational applications, including vaccine design and therapeutic development.
I am passionate about bridging fundamental molecular biology with applied biomedical research, leveraging my expertise to understand disease mechanisms and contr
I am a molecular biologist and postdoctoral researcher with expertise in protein biochemistry and translational research. My Ph.D. work focused on alpha-1-antitrypsin (AAT), a key plasma inhibitor of serine proteases, with a particular emphasis on the functional effects of amino acid variations in its Reactive Center Loop (RCL) and their impact on protease inhibition and secretion. During this period, I characterized 23 RCL variants—including naturally occurring mutations—and assessed their secretion efficiency and anti-elastase activity using cellular models, immunoblotting, and enzymatic assays. Additionally, I developed a polymeric AAT standard for ELISA-based quantification of Z-AAT polymers in plasma, contributing to the understanding of the molecular basis of disease severity in ZZ homozygous patients.
Currently, as a postdoctoral fellow, I investigate the role of post-translational modifications (PTMs), particularly N-glycosylation, in viral protein function and host-pathogen interactions. I combine advanced virological models, including pseudovirus systems, with proteomics and functional assays to study how specific modifications affect viral infectivity and immune recognition. My work aims to integrate molecular insights into translational applications, including vaccine design and therapeutic development.
I am passionate about bridging fundamental molecular biology with applied biomedical research, leveraging my expertise to understand disease mechanisms and contr